Yazar "Mercan, Rıdvan" için listeleme
-
A multicenter report of biologic agents for the treatment of secondary amyloidosis in Turkish rheumatoid arthritis and ankylosing spondylitis patients
Pamuk, Ömer Nuri; Kalyoncu, Umut; Aksu, Kenan; Omma, Ahmet; Pehlivan, Yavuz; Çağatay, Yonca; Küçükşahin, Orhan; Dönmez, Salim; Çetin Yıldırım, Gözde; Mercan, Rıdvan; Bayındır, Özün; Çefle, Ayşe; Yıldız, Fatih; Balkarlı, Ayşe; Kılıç, Levent; Çakır, Necati; Kısacık, Bünyamin; Öksüz, Mustafa Ferhat; Çobankara, Veli; Onat, Ahmet Mesut; Sayarlıoğlu, Mehmet; Öztürk, Mehmet Akif; Pamuk, Gülsüm Emel; Akkoç, Nurullah (Springer Heidelberg, 2016)In this multicenter, retrospective study, we evaluated the efficacy and safety of biologic therapies, including anti-TNFs, in secondary (AA) amyloidosis patients with ankylosing spondylitis (AS) and rheumatoid arthritis ... -
PsART-ID inception cohort: Clinical characteristics, treatment choices and outcomes of patients with psoriatic arthritis
Ayan, Gizem; Aydın, Sibel Zehra; Kimyon, Gezmiş; Özişler, Cem; Tinazzi, İlaria; Doğru, Atalay; Omma, Ahmet; Kılıç, Levent; Yılmaz, Sema; Küçükşahin, Orhan; Gönüllü, Emel; Yıldız, Fatih; Can, Meryem; Balkarlı, Ayşe; Solmaz, Dilek; Dalkılıç, Ediz; Bayındır, Özün; Yıldırım Çetin, Gözde; Ergülü Esmen, Serpil; Ersözlü, Emine Duygu; Duruöz, Mehmet Tuncay; Akyol, Lütfi; Küçük, Adem; Beş, Cemal; Çınar, Muhammet; Erden, Abdülsamet; Mercan, Rıdvan; Bakırcı, Sibel; Kaşifoğlu, Timuçin; Yazısız, Veli; Kalyoncu, Umut (Oxford University Press, 2021)Objectives: Our aim is to understand clinical characteristics, real-life treatment strategies, outcomes of early PsA patients and determine the differences between the inception and established PsA cohorts.Methods: PsArt-ID ...